Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41


Draft Genome Sequences of Antimicrobial-Resistant Shigella Clinical Isolates from Pakistan.

Lomonaco S, Lascols C, Crawford MA, Anderson K, Hodge DR, Fisher DJ, Pillai SP, Morse SA, Khan E, Hughes MA, Allard MW, Sharma SK.

Microbiol Resour Announc. 2019 Jul 25;8(30). pii: e00500-19. doi: 10.1128/MRA.00500-19.


Genome Sequences of Penicillin-Resistant Bacillus anthracis Strains.

Gargis AS, Lascols C, McLaughlin HP, Conley AB, Hoffmaster AR, Sue D.

Microbiol Resour Announc. 2019 Jan 10;8(2). pii: e01122-18. doi: 10.1128/MRA.01122-18. eCollection 2019 Jan.


Analysis of Whole-Genome Sequences for the Prediction of Penicillin Resistance and β-Lactamase Activity in Bacillus anthracis.

Gargis AS, McLaughlin HP, Conley AB, Lascols C, Michel PA, Gee JE, Marston CK, Kolton CB, Rodriguez-R LM, Hoffmaster AR, Weigel LM, Sue D.

mSystems. 2018 Dec 11;3(6). pii: e00154-18. doi: 10.1128/mSystems.00154-18. eCollection 2018 Nov-Dec.


Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates.

Lomonaco S, Crawford MA, Lascols C, Timme RE, Anderson K, Hodge DR, Fisher DJ, Pillai SP, Morse SA, Khan E, Hughes MA, Allard MW, Sharma SK.

PLoS One. 2018 Jun 8;13(6):e0198526. doi: 10.1371/journal.pone.0198526. eCollection 2018.


CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens.

Crawford MA, Fisher DJ, Leung LM, Lomonaco S, Lascols C, Cannatelli A, Giani T, Rossolini GM, Doi Y, Goodlett DR, Allard MW, Sharma SK, Khan E, Ernst RK, Hughes MA.

MBio. 2017 Nov 14;8(6). pii: e01549-17. doi: 10.1128/mBio.01549-17.


Rapid Filter-Based Detection and Culture of Burkholderia pseudomallei from Small Volumes of Urine.

Michel PA, Lascols C, Gee JE, Weigel LM, Sue D.

J Clin Microbiol. 2017 Sep;55(9):2698-2707. doi: 10.1128/JCM.00764-17. Epub 2017 Jun 21.


Genome Sequences of Multidrug-Resistant, Colistin-Susceptible and -Resistant Klebsiella pneumoniae Clinical Isolates from Pakistan.

Crawford MA, Timme R, Lomonaco S, Lascols C, Fisher DJ, Sharma SK, Strain E, Allard MW, Brown EW, McFarland MA, Croley T, Hammack TS, Weigel LM, Anderson K, Hodge DR, Pillai SP, Morse SA, Khan E, Hughes MA.

Genome Announc. 2016 Dec 15;4(6). pii: e01419-16. doi: 10.1128/genomeA.01419-16.


Rapid Antimicrobial Susceptibility Testing of Bacillus anthracis, Yersinia pestis, and Burkholderia pseudomallei by Use of Laser Light Scattering Technology.

Bugrysheva JV, Lascols C, Sue D, Weigel LM.

J Clin Microbiol. 2016 Jun;54(6):1462-1471. doi: 10.1128/JCM.03251-15. Epub 2016 Mar 16.


In vitro susceptibility and distribution of beta-lactamases in Enterobacteriaceae causing intra-abdominal infections in North America 2010-2011.

Hoban DJ, Badal R, Bouchillon S, Hackel M, Kazmierczak K, Lascols C, Hawser S.

Diagn Microbiol Infect Dis. 2014 Jul;79(3):367-72. doi: 10.1016/j.diagmicrobio.2014.03.026. Epub 2014 Apr 12.


Molecular epidemiology of Enterobacteriaceae that produce VIMs and IMPs from the SMART surveillance program.

Peirano G, Lascols C, Hackel M, Hoban DJ, Pitout JD.

Diagn Microbiol Infect Dis. 2014 Mar;78(3):277-81. doi: 10.1016/j.diagmicrobio.2013.11.024. Epub 2013 Dec 6.


Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations.

Hackel M, Lascols C, Bouchillon S, Hilton B, Morgenstern D, Purdy J.

Vaccine. 2013 Oct 1;31(42):4881-7. doi: 10.1016/j.vaccine.2013.07.054. Epub 2013 Aug 6.


Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America.

Lascols C, Peirano G, Hackel M, Laupland KB, Pitout JD.

Antimicrob Agents Chemother. 2013 Jan;57(1):130-6. doi: 10.1128/AAC.01686-12. Epub 2012 Oct 15.


Laboratory detection of Enterobacteriaceae that produce carbapenemases.

Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JD.

J Clin Microbiol. 2012 Dec;50(12):3877-80. doi: 10.1128/JCM.02117-12. Epub 2012 Sep 19.


Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009-2010.

Hoban DJ, Lascols C, Nicolle LE, Badal R, Bouchillon S, Hackel M, Hawser S.

Diagn Microbiol Infect Dis. 2012 Sep;74(1):62-7. doi: 10.1016/j.diagmicrobio.2012.05.024. Epub 2012 Jul 2.


Low frequency of ertapenem-resistant intra-abdominal isolates of Escherichia coli from Latin America: susceptibility, ESBL-occurrence, and molecular characterisation (SMART 2008-2009).

Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Hackel MA, Lascols CA, Villegas MV, Rossi F.

J Chemother. 2012 Feb;24(1):6-11. doi: 10.1179/1120009X12Z.0000000003.


Using nucleic acid microarrays to perform molecular epidemiology and detect novel β-lactamases: a snapshot of extended-spectrum β-lactamases throughout the world.

Lascols C, Hackel M, Hujer AM, Marshall SH, Bouchillon SK, Hoban DJ, Hawser SP, Badal RE, Bonomo RA.

J Clin Microbiol. 2012 May;50(5):1632-9. doi: 10.1128/JCM.06115-11. Epub 2012 Feb 8.


NDM-1-producing Klebsiella pneumoniae in Mauritius.

Poirel L, Lascols C, Bernabeu S, Nordmann P.

Antimicrob Agents Chemother. 2012 Jan;56(1):598-9. doi: 10.1128/AAC.05639-11. Epub 2011 Oct 17. No abstract available.


Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009).

Lascols C, Hackel M, Marshall SH, Hujer AM, Bouchillon S, Badal R, Hoban D, Bonomo RA.

J Antimicrob Chemother. 2011 Sep;66(9):1992-7. doi: 10.1093/jac/dkr240. Epub 2011 Jun 14.


Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates.

Hawser SP, Bouchillon SK, Lascols C, Hackel M, Hoban DJ, Badal RE, Woodford N, Livermore DM.

Antimicrob Agents Chemother. 2011 Aug;55(8):3917-21. doi: 10.1128/AAC.00070-11. Epub 2011 Jun 13.


Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009).

Hawser SP, Bouchillon SK, Lascols C, Hackel M, Hoban DJ, Badal RE, Cantón R.

Clin Microbiol Infect. 2012 Mar;18(3):253-9. doi: 10.1111/j.1469-0691.2011.03550.x. Epub 2011 Jun 2.


In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.

Lascols C, Legrand P, Mérens A, Leclercq R, Muller-Serieys C, Drugeon HB, Kitzis MD, Reverdy ME, Roussel-Delvallez M, Moubareck C, Brémont S, Miara A, Gjoklaj M, Soussy CJ.

Int J Antimicrob Agents. 2011 Mar;37(3):235-9. doi: 10.1016/j.ijantimicag.2010.11.035. Epub 2011 Feb 4.


In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.

Lascols C, Legrand P, Mérens A, Leclercq R, Armand-Lefevre L, Drugeon HB, Kitzis MD, Muller-Serieys C, Reverdy ME, Roussel-Delvallez M, Moubareck C, Lemire A, Miara A, Gjoklaj M, Soussy CJ.

Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):475-82. doi: 10.1007/s10096-010-1117-6. Epub 2010 Nov 19. Review.


Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori.

Cambau E, Allerheiligen V, Coulon C, Corbel C, Lascols C, Deforges L, Soussy CJ, Delchier JC, Megraud F.

J Clin Microbiol. 2009 Nov;47(11):3600-7. doi: 10.1128/JCM.00744-09. Epub 2009 Sep 16.


Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.

Cambau E, Matrat S, Pan XS, Roth Dit Bettoni R, Corbel C, Aubry A, Lascols C, Driot JY, Fisher LM.

J Antimicrob Chemother. 2009 Mar;63(3):443-50. doi: 10.1093/jac/dkn528. Epub 2009 Jan 15.


The pentapeptide repeat proteins MfpAMt and QnrB4 exhibit opposite effects on DNA gyrase catalytic reactions and on the ternary gyrase-DNA-quinolone complex.

Mérens A, Matrat S, Aubry A, Lascols C, Jarlier V, Soussy CJ, Cavallo JD, Cambau E.

J Bacteriol. 2009 Mar;191(5):1587-94. doi: 10.1128/JB.01205-08. Epub 2008 Dec 5.


First detection of plasmid-mediated quinolone resistance in the community setting and in hospitalized patients in Switzerland.

Liassine N, Zulueta-Rodriguez P, Corbel C, Lascols C, Soussy CJ, Cambau E.

J Antimicrob Chemother. 2008 Nov;62(5):1151-2. doi: 10.1093/jac/dkn295. Epub 2008 Jul 31. No abstract available.


A plasmid-borne Shewanella algae Gene, qnrA3, and its possible transfer in vivo between Kluyvera ascorbata and Klebsiella pneumoniae.

Lascols C, Podglajen I, Verdet C, Gautier V, Gutmann L, Soussy CJ, Collatz E, Cambau E.

J Bacteriol. 2008 Aug;190(15):5217-23. doi: 10.1128/JB.00243-08. Epub 2008 May 30.


Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes.

Cesaro A, Bettoni RR, Lascols C, Mérens A, Soussy CJ, Cambau E.

J Antimicrob Chemother. 2008 May;61(5):1007-15. doi: 10.1093/jac/dkn077. Epub 2008 Mar 6.


[In vitro activity of levofloxacin against Escherichia coli strains in acute pyelonephritis, in France in 2005].

Soussy CJ, Lascols C, Dib-Smahi C; et le Groupe d'étude multicentrique.

Med Mal Infect. 2007 Nov;37(11):773-5. Epub 2007 Oct 23. French.


Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.

Cattoir V, Nectoux J, Lascols C, Deforges L, Delchier JC, Megraud F, Soussy CJ, Cambau E.

Int J Antimicrob Agents. 2007 Apr;29(4):389-96. Epub 2007 Feb 15.


Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene.

Lascols C, Robert J, Cattoir V, Bébéar C, Cavallo JD, Podglajen I, Ploy MC, Bonnet R, Soussy CJ, Cambau E.

Int J Antimicrob Agents. 2007 Apr;29(4):402-9. Epub 2007 Jan 23.


In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.

Cattoir V, Lesprit P, Lascols C, Denamur E, Legrand P, Soussy CJ, Cambau E.

J Antimicrob Chemother. 2006 Nov;58(5):1054-7. Epub 2006 Sep 19.


Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002-2005.

Cambau E, Lascols C, Sougakoff W, Bébéar C, Bonnet R, Cavallo JD, Gutmann L, Ploy MC, Jarlier V, Soussy CJ, Robert J.

Clin Microbiol Infect. 2006 Oct;12(10):1013-20.


[Investigation of the new QNR-based mechanism of quinolone resistance among enterobacterial strains isolated in Henri-Mondor hospital 2002-2005].

Honoré S, Lascols C, Malin D, Targaouchi R, Cattoir V, Legrand P, Soussy CJ, Cambau E.

Pathol Biol (Paris). 2006 May;54(5):270-9. Epub 2006 Feb 13. French.


Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods.

Muller-Serieys C, Drugeon HB, Etienne J, Lascols C, Leclercq R, Nguyen J, Soussy CJ.

Clin Microbiol Infect. 2004 Mar;10(3):242-6.


Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori.

Tankovic J, Lascols C, Sculo Q, Petit JC, Soussy CJ.

Antimicrob Agents Chemother. 2003 Dec;47(12):3942-4.


Fast and accurate quantitative detection of Helicobacter pylori and identification of clarithromycin resistance mutations in H. pylori isolates from gastric biopsy specimens by real-time PCR.

Lascols C, Lamarque D, Costa JM, Copie-Bergman C, Le Glaunec JM, Deforges L, Soussy CJ, Petit JC, Delchier JC, Tankovic J.

J Clin Microbiol. 2003 Oct;41(10):4573-7.


Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.

Bachoual R, Ouabdesselam S, Mory F, Lascols C, Soussy CJ, Tankovic J.

Microb Drug Resist. 2001 Fall;7(3):257-61.


Effect of pH on the susceptibility of Helicobacter pylori to the ketolide telithromycin (HMR 3647) and clarithromycin.

Lascols C, Bryskier A, Soussy CJ, Tanković J.

J Antimicrob Chemother. 2001 Nov;48(5):738-40. No abstract available.


Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.

Tankovic J, Lamarque D, Lascols C, Soussy CJ, Delchier JC.

Pathol Biol (Paris). 2001 Sep;49(7):528-33.


Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.

Tankovic J, Lamarque D, Lascols C, Soussy CJ, Delchier JC.

Aliment Pharmacol Ther. 2001 May;15(5):707-13.

Supplemental Content

Loading ...
Support Center